Pembrolizumab 400 mg every 6 weeks as first-line therapy for advanced melanoma (KEYNOTE-555): Results from cohort B of an open-label, phase 1 study von Cohen, Graham, Rapoport, Bernardo, Chan, Sze W, Ruff, Paul, Arance, Ana, Mujika Eizmendi, Karmele, Houghton, Baerin, Brown, Michael P, Zielinski, Robert M, Muñoz Couselo, Eva, Lyle, Megan, Anderson, James R, Jain, Lokesh, de Alwis, Dinesh, Lala, Mallika, Akala, Omobolaji, Chartash, Elliot, Jacobs, Conrad

Volltext

Immune‐related hepatitis related to checkpoint inhibitors: Clinical and prognostic factors von Riveiro‐Barciela, Mar, Barreira‐Díaz, Ana, Vidal‐González, Judit, Muñoz‐Couselo, Eva, Martínez‐Valle, Fernando, Viladomiu, Lluís, Mínguez, Beatriz, Ortiz‐Velez, Carolina, Castells, Lluís, Esteban, Rafael, Buti, María

Volltext

Loss of USP28-mediated BRAF degradation drives resistance to RAF cancer therapies von Saei, Azad, Palafox, Marta, Benoukraf, Touati, Kumari, Nishi, Jaynes, Patrick William, Iyengar, Prasanna Vasudevan, Muñoz-Couselo, Eva, Nuciforo, Paolo, Cortés, Javier, Nötzel, Christopher, Kumarakulasinghe, Nesaretnam Barr, Richard, John Lalith Charles, Bin Adam Isa, Zul Fazreen, Pang, Brendan, Guzman, Marta, Siqin, Zhou, Yang, Henry, Tam, Wai Leong, Serra, Violeta, Eichhorn, Pieter Johan Adam

Volltext

An algorithm based on immunotherapy discontinuation and liver biopsy spares corticosteroids in two thirds of cases of severe checkpoint inhibitor‐induced liver injury von Riveiro‐Barciela, Mar, Barreira‐Díaz, Ana, Salcedo, María‐Teresa, Callejo‐Pérez, Ana, Muñoz‐Couselo, Eva, Iranzo, Patricia, Ortiz‐Velez, Carolina, Cedrés, Susana, Díaz‐Mejía, Nely, Ruiz‐Cobo, Juan Carlos, Morales, Rafael, Aguilar‐Company, Juan, Zamora, Ester, Oliveira, Mafalda, Sanz‐Martínez, María‐Teresa, Viladomiu, Lluis, Martínez‐Gallo, Mónica, Felip, Enriqueta, Buti, María

Volltext

Initial Evidence for the Efficacy of Naporafenib in Combination With Trametinib in NRAS -Mutant Melanoma: Results From the Expansion Arm of a Phase Ib, Open-Label Study von de Braud, Filippo, Dooms, Christophe, Heist, Rebecca S, Lebbe, Celeste, Wermke, Martin, Gazzah, Anas, Schadendorf, Dirk, Rutkowski, Piotr, Wolf, Jürgen, Ascierto, Paolo A, Gil-Bazo, Ignacio, Kato, Shumei, Wolodarski, Maria, McKean, Meredith, Muñoz Couselo, Eva, Sebastian, Martin, Santoro, Armando, Cooke, Vesselina, Manganelli, Luca, Wan, Kitty, Gaur, Anil, Kim, Jaeyeon, Caponigro, Giordano, Couillebault, Xuân-Mai, Evans, Helen, Campbell, Catarina D, Basu, Sumit, Moschetta, Michele, Daud, Adil

Volltext

SEOM-GEM clinical guidelines for cutaneous melanoma (2023) von Márquez-Rodas, Iván, Muñoz Couselo, Eva, Rodríguez Moreno, Juan F., Arance Fernández, Ana Mª, Berciano Guerrero, Miguel Ángel, Campos Balea, Begoña, de la Cruz Merino, Luis, Espinosa Arranz, Enrique, García Castaño, Almudena, Berrocal Jaime, Alfonso

Volltext

Evaluation of the Effects of Repeat‐Dose Dabrafenib on the Single‐Dose Pharmacokinetics of Rosuvastatin (OATP1B1/1B3 Substrate) and Midazolam (CYP3A4 Substrate) von Nebot, Noelia, Won, Christina S., Moreno, Victor, Muñoz‐Couselo, Eva, Lee, Dung‐Yang, Gasal, Eduard, Bouillaud, Emmanuel

Volltext

Pembrolizumab versus investigator-choice chemotherapy for metastatic triple-negative breast cancer (KEYNOTE-119): a randomised, open-label, phase 3 trial von Winer, Eric P, Lipatov, Oleg, Im, Seock-Ah, Goncalves, Anthony, Muñoz-Couselo, Eva, Lee, Keun Seok, Schmid, Peter, Tamura, Kenji, Testa, Laura, Witzel, Isabell, Ohtani, Shoichiro, Turner, Nicholas, Zambelli, Stefania, Harbeck, Nadia, Andre, Fabrice, Dent, Rebecca, Zhou, Xuan, Karantza, Vassiliki, Mejia, Jaime, Cortes, Javier

Volltext

Phase 1, first-in-human study of TYRP1-TCB (RO7293583), a novel TYRP1-targeting CD3 T-cell engager, in metastatic melanoma: active drug monitoring to assess the impact of immune re... von Spreafico, Anna, Couselo, Eva Muñoz, Irmisch, Anja, Bessa, Juliana, Au-Yeung, George, Bechter, Oliver, Svane, Inge Marie, Sanmamed, Miguel F, Gambardella, Valentina, McKean, Meredith, Callahan, Margaret, Dummer, Reinhard, Klein, Christian, Umaña, Pablo, Justies, Nicole, Heil, Florian, Fahrni, Linda, Opolka-Hoffmann, Eugenia, Waldhauer, Inja, Bleul, Conrad, Staack, Roland F, Karanikas, Vaios, Fowler, Stephen

Volltext

Contribution of tumour and immune cells to PD‐L1 expression as a predictive biomarker in metastatic triple‐negative breast cancer: exploratory analysis from KEYNOTE‐119 von Cortes, Javier, Winer, Eric P, Lipatov, Oleg, Im, Seock‐Ah, Gonçalves, Anthony, Muñoz‐Couselo, Eva, Lee, Keun Seok, Schmid, Peter, Tamura, Kenji, Testa, Laura, Witzel, Isabell, Ohtani, Shoichiro, Hund, Stephanie, Kulangara, Karina, Karantza, Vassiliki, Mejia, Jaime A, Ma, Junshui, Jelinic, Petar, Huang, Lingkang, Pruitt, Scott K, Emancipator, Kenneth

Volltext

A slow-cycling LGR5 tumour population mediates basal cell carcinoma relapse after therapy von Sánchez-Danés, Adriana, Larsimont, Jean-Christophe, Liagre, Mélanie, Muñoz-Couselo, Eva, Lapouge, Gaëlle, Brisebarre, Audrey, Dubois, Christine, Suppa, Mariano, Sukumaran, Vijayakumar, del Marmol, Véronique, Tabernero, Josep, Blanpain, Cédric

Volltext

Mediastinal FDG-positive lymph nodes simulating melanoma progression: drug-induced sarcoidosis like/lymphadenopathy related to ipilimumab von González-Cruz, Carlos, Bodet, Domingo, Muñoz-Couselo, Eva, García-Patos, Vicente

Volltext

Health-Related Quality of Life with Pembrolizumab in Patients with Locally Advanced or Recurrent or Metastatic Cutaneous Squamous Cell Carcinoma: KEYNOTE-629 von Bratland, Åse, Munoz-Couselo, Eva, Mortier, Laurent, Roshdy, Osama, González, Rene, Schachter, Jacob, Arance, Ana M., Grange, Florent, Meyer, Nicolas, Joshi, Abhishek Jagdish, Billan, Salem, Hughes, Brett G. M., Grob, Jean-Jacques, Ramakrishnan, Karthik, Ge, Joy, Gumuscu, Burak, Swaby, Ramona F., Gutzmer, Ralf

Volltext

Efficacy and safety of cosibelimab, an anti-PD-L1 antibody, in metastatic cutaneous squamous cell carcinoma von Clingan, Philip, Ladwa, Rahul, Brungs, Daniel, Harris, Dean Laurence, McGrath, Margaret, Arnold, Susan, Coward, Jermaine, Fourie, Samuel, Kurochkin, Andriy, Malan, Daniel R, Mant, Andrew, Sharma, Vinay, Shue, Hong, Tazbirkova, Andrea, Berciano-Guerrero, Miguel-Angel, Charoentum, Chaiyut, Dalle, Stéphane, Dechaphunkul, Arunee, Dudnichenko, Oleksandr, Koralewski, Piotr, Lugowska, Iwona, Montaudié, Henri, Muñoz-Couselo, Eva, Sriuranpong, Virote, Oliviero, James, Desai, Jayesh

Volltext

Cancer immunotherapy in special challenging populations: recommendations of the Advisory Committee of Spanish Melanoma Group (GEM) von Gonzalez-Cao, Maria, Puertolas, Teresa, Riveiro, Mar, Muñoz-Couselo, Eva, Ortiz, Carolina, Paredes, Roger, Podzamczer, Daniel, Manzano, Jose Luis, Molto, Jose, Revollo, Boris, Carrera, Cristina, Mateu, Lourdes, Fancelli, Sara, Espinosa, Enrique, Clotet, Bonaventura, Martinez-Picado, Javier, Cerezuela, Pablo, Soria, Ainara, Marquez-Rodas, Ivan, Mandala, Mario, Berrocal, Alfonso

Volltext

Acute liver failure due to immune-mediated hepatitis successfully managed with plasma exchange: New settings call for new treatment strategies? von Riveiro-Barciela, Mar, Muñoz-Couselo, Eva, Fernandez-Sojo, Jesús, Diaz-Mejia, Nely, Parra-López, Rafael, Buti, María

Volltext

Baseline biomarkers of efficacy and on-treatment immune-profile changes associated with bempegaldesleukin plus nivolumab von Gogas, Helen, Ravimohan, Shruthi, Datta, Antara, Chhibber, Aparna, Couselo, Eva Muñoz, Diab, Adi, Pereira, Caio, Quéreux, Gaëlle, Sandhu, Shahneen, Curti, Brendan, Khushalani, Nikhil I., Taylor, Matthew H., Daniels, Gregory A., Spreafico, Anna, Meniawy, Tarek, Van Den Eertwegh, Alfons J. M., Sun, Yongliang, Arriaga, Yull, Zhou, Ming, Long, Georgina V., Lebbé, Céleste

Volltext

The Low Incidence of Viral Hepatitis Reactivation Among Subjects on Immunotherapy Reduces the Impact of Suboptimal Screening Rate von Aceituno, Laia, Bañares, Juan, Ruiz-Ortega, Lourdes, Callejo-Pérez, Ana, Muñoz-Couselo, Eva, Ortiz-Velez, Carolina, Díaz-Mejía, Nely, Barreira-Díaz, Ana, Carreras, María José, Farriols, Anna, Buti, María, Riveiro-Barciela, Mar

Volltext

A CT-based Radiomics Signature Is Associated with Response to Immune Checkpoint Inhibitors in Advanced Solid Tumors von Ligero, Marta, Garcia-Ruiz, Alonso, Viaplana, Cristina, Villacampa, Guillermo, Raciti, Maria, Landa, Jaid, Matos, Ignacio, Martin-Liberal, Juan, Ochoa-de-Olza, Maria, Hierro, Cinta, Mateo, Joaquin, Gonzalez, Macarena, Morales-Barrera, Rafael, Suarez, Cristina, Rodon, Jordi, Elez, Elena, Brana, Irene, Munoz-Couselo, Eva, Oaknin, Ana, Fasani, Roberta, Nuciforo, Paolo, Gil, Debora, Rubio-Perez, Carlota, Seoane, Joan, Felip, Enriqueta, Escobar, Manuel, Tabernero, Josep, Carles, Joan, Dienstmann, Rodrigo, Garralda, Elena, Perez-Lopez, Raquel

Volltext

Current Perspectives and Novel Strategies of NRAS-Mutant Melanoma von Garcia-Alvarez, Alejandro, Ortiz, Carolina, Munoz-Couselo, Eva

Volltext